Table 1.
Sr. No.
|
Strain
|
Mutation
|
Host entry
|
Location
|
Time of first report
|
Ref.
|
1 | Alpha (B.1.1.7) | N501Y mutation on the RBD | The affinity between RBD and ACE2 is significantly increased | United Kingdom | December 2020 | [40-42] |
2 | Beta (B.1.351) | N501Y mutation on the RBD N417/K848/Y501 | The affinity between RBD and ACE2 is significantly increased | South Africa | December 2020 | [41-43] |
3 | Gamma (P.1) | N501Y mutation on the RBD N417/K848/Y501 | The affinity between RBD and ACE2 is significantly increased | Brazil | January 2021 | [41,42,44] |
4 | Delta (B.1.617.2) | Absence of N501Y mutation | No effect | India | December 2020 | [41,42] |
5 | Omicron (B.1.1.529) | N501Y mutation on the RBD | The affinity between RBD and ACE2 is significantly increased | South Africa | November 2021 | [41,42] |
RBD: Receptor binding domain; ACE2: Angiotensin-converting enzyme 2.